Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net loss	$ (6,314,047)	$ (4,604,297)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	113,735	160,464
Share-based compensation expense	761,344	570,273
Allowance for bad debt	362,176
Change in fair value of liability classified warrants	(416,796)	(1,805,319)
Changes in operating assets and liabilities:
Trade and other receivables	232,903	150,823
Related party receivable		71,638
Prepaid expenses	(235,946)	(154,271)
ROU and other assets	24,938	(4,000)
Accounts payable and accrued expenses	340,673	(25,487)
Accrued bonuses		(418,625)
Other current liabilities	(48,110)	26,288
Lease and other long term liabilities	(27,618)	(1,876)
Net cash used in operating activities	(5,206,748)	(6,034,389)
Cash flows from investing activities:
Maturity of short-term investments		5,000,000
Net cash provided by investing activities		5,000,000
Cash flows from financing activities:
Net proceeds from the sale of our common stock and warrants	6,552,842
Proceeds from warrant exercises	131
Proceeds from short-term note payable	414,320	349,578
Payments of short-term note payable	(241,061)	(247,817)
Net cash provided by financing activities	6,726,232	101,761
Effects of exchange rates on cash	(6,758)	(5,383)
Net increase (decrease) in cash and cash equivalents	1,512,726	(938,011)
Cash and cash equivalents, beginning of period	5,787,110	6,674,940
Cash and cash equivalents, end of period	7,299,836	5,736,929
Supplemental disclosure of cash flows information:
Cash paid for interest	$ 4,437	$ 4,190